NCT02996305 - A Study in Adults and Adolescents With Angelman Syndrome (STARS) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 7, 2018

Study Completion Date

August 6, 2018

Conditions

Angelman Syndrome

Interventions

DRUG

OV101 Regimen 1

DRUG

OV101 regimen 2

OTHER

Placebo

Trial Locations (13)

Ovid Therapeutics Investigative Site, Phoenix

Ovid Therapeutics Investigative Site, San Diego

Ovid Therapeutics Investigative Site, Gainesville

Ovid Therapeutics Investigative Site, Tampa

Ovid Therapeutics Investigative Site, Atlanta

Ovid Therapeutics Investigative Site, Chicago

Ovid Therapeutics Investigative Site, Boston

Ovid Therapeutics Investigative Site, Lexington

Ovid Therapeutics Investigative Site, Cincinnati

Ovid Therapeutics Investigative Site, Media

Ovid Therapeutics Investigative Site, Greenwood

Ovid Therapeutics Investigative Site, Nashville

Ovid Therapeutics Investigative Site, Ramat Gan